Fonts Size

Change Color


Healthcare facilities are required to complete the Training Programme on Abu Dhabi Healthcare Guidelines for Health Media & Advertising System as mentioned in circular number 26/2023, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

Research and Innovation Center

Research and Innovation Programs

Through our programs DOH ensures that safe and effective drugs are available to improve the health of the people in Abu Dhabi.

Real World Data/Evidence Research

    Real-world data are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources, such as electronic health records, administrative claims and medical product/device registries. Research conducted using real world data can generate real world evidence to support regulatory, clinical and reimbursement decisions and to encourage further research.

    Below are reports on RWD research projects:
    Note: The perspectives and viewpoints presented in these reports are those of the authors and do not represent the official policies or stances of the Department of Health Abu Dhabi (DOH).

    For more information on RWD/RWE research, please contact: DMP@doh.gov.ae

  • The increasing antimicrobial resistance is imposing scientific, economic, governance and societal challenges endangering public health worldwide.  Coordinated approach at global, regional, local, community and even at institutional level is much needed.
  • Antimicrobials are in general overused/ misused in healthcare facilities. DOH is more concerned about broad-spectrum antibiotics misuse for minor outpatient conditions. Overuse/ misuse of antimicrobials is resulting in increasing antibiotic resistance limiting treatment options.
  • DOH requires all hospitals and day surgery centers in the Emirate of Abu Dhabi to establish a functional Antimicrobial stewardship program
  • Antimicrobial Stewardship Program (ASP)
  • ASP represents a multidisciplinary coordinated programmatic effort that promotes the optimal selection of antimicrobial treatment, dosage and duration that results in the best possible clinical outcome for the treatment or prevention of infection, with minimal toxicity to the patient and minimal impact on the subsequent antibiotic resistance profile. 
  • Effective implementation of ASP requires strong commitment, investment and resource allocation from hospital management that would support the business case of antimicrobial stewardship.  It also entails training of key staff members, in addition to the development of appropriate processes and supporting systems.  
  • DOH has adopted multi-faceted, coordinated comprehensive strategy to curb the increasing antimicrobial resistance. The main objectives of DOH ASP Program are as below
  • No. Purpose/ Objective Activities
    1 Evidence Generation – Decision-making Data Analyses – Antibiotic consumption, dashboard development, use of data analytics and Ai tools
    2 Educational Sessions/ Awareness DOH has conducted 14 educational sessions - Targeted facilities/ physicians using data analyses
    3 Design interventions Regulatory, administrative, reimbursement, educational
    4 Regulatory Framework and Enforcement ASP - standard and guidelines published, audit, OTC sale, Annual ASP reports
    5 Stakeholders involvement, contributing in National Committees, Institutional uplifting, improve governance Contributed in NAP development, WHO assessment – Involved healthcare facilities leadership, regular engagement, Foster collaboration within and across facilities
    6 Administrative Supply issues, Access control (balancing reimbursement plans), Formulary restrictions
    7 Monitoring and Evaluation Regular data analyses, pre and post assessments
    Harmonizing with Global Standards
  • GS1 - a global standard of barcoding offers the functionalities and solutions to strengthen drug supply chains.  Full implementation of GS1 barcoding system will enable us to monitor drug supplies and take corrective actions to minimize supply interruptions, having quality products available, prevent entry of counterfeit drugs and reduce unnecessary higher drug cost.
  • GS1 standards are being adopted by most countries. Several Gulf countries are actively working towards full implementation of GS1 barcoding requirements.
  • The main objectives of the GS1 Barcoding are:
  • Streamlining drug supply and enhancing efficiency, transparency and reliability
  • Implementing unified GS1 barcoding on drugs used along the entire supply chain
  • Centralize tracking of drug supplies - Utilize barcode scanning to obtain drug supply information through digital portal for better planning and appropriate actions
  • Oversight inventory management of drugs supplied to AD emirate
  • Address/ mitigate weaknesses in drug supply (minimize drug shortages and supply interruptions)
  • Develop drug supply database for future analyses
  • Support DoH Digital Health Strategy
  • Enhance patient safety across the Emirate of Abu Dhabi
  • Actions Taken
  • DoH Chairman decree 39/2020 issued on 21st July 2020 to mandate GS1 barcoding on pharmaceuticals
  • Stakeholder consultation meetings held with stakeholders: MOHAP & DHA, CCAD, SEHA, RAFED, Pharma Manufacturing companies, Drug stores and suppliers.
  • Created DOH account on (GS1 database)
  • Monitoring the implementation and performance of companies on BrandSync

Subscribe for updates

Thanks for Subscribing

Last updated: 21 May 2024

Mobile For an optimal experience please
rotate your device to portrait mode